Ztlido is a topical medication used to treat postherpetic neuralgia (PHN), a type of nerve pain that can occur after shingles [1]. It is a lidocaine medicated patch [1].
How effective is Ztlido for pain relief?
Ztlido is indicated for the topical treatment of PHN [1]. The efficacy of Ztlido was evaluated in clinical studies.
What are the potential side effects of Ztlido?
The most common side effects reported with Ztlido include skin reactions at the application site, such as redness, itching, or rash [1]. Other side effects may include nausea, fatigue, and headache [1].
How does Ztlido work?
Ztlido is a lidocaine patch that works by numbing the area of pain [1]. Lidocaine is a local anesthetic that blocks nerve signals in the body [1]. When applied to the skin, it can help to reduce the sensation of pain [1].
What is the recommended dosage and application for Ztlido?
Ztlido is a topical patch applied to the affected area [1]. The recommended dosage and duration of application should be followed as prescribed by a healthcare professional [1]. It is important to adhere to the instructions for use to ensure efficacy and safety [1].
How does Ztlido compare to other treatments for postherpetic neuralgia?
Other treatment options for PHN include oral medications such as anticonvulsants and antidepressants, as well as other topical agents [2]. Ztlido offers a localized approach to pain relief, which may be preferred by some patients seeking to minimize systemic exposure to medication [1, 2].
When does the patent for Ztlido expire?
Information regarding the specific patent expiry for Ztlido can be found on specialized drug patent databases. DrugPatentWatch.com provides detailed information on drug patents and their expiration dates [3].
Who manufactures Ztlido?
Ztlido is manufactured by Sorrento Therapeutics [4].